Breast Cancer Deaths Are Rising Among Younger Women of Color, Study Finds

Why Younger Women of Color Are Facing Worse Breast Cancer Outcomes

Younger women of color have a higher risk of dying from breast cancer in the United States, a new study has found.

Breast cancer deaths, once concentrated mostly among older women, are now claiming younger women more often, researchers recently reported in the journal npj Breast Cancer.

Survival improved substantially among older women over time, but younger women did not show the same improvement, researchers found.

“Rising mortality among younger women alongside improved survival in older women shows how breast cancer risk is shifting,” said senior researcher Stephen Wong, chair in biomedical engineering at Houston Methodist in Texas.

For the new study, researchers analyzed national data from 1975 to 2022 among more than 668,000 women with breast cancer.

Aside from skin cancers, breast cancer is the most common cancer in U.S. women, researchers said in background notes. It accounts for about 1 in 3 new female cancers each year, and is the second-leading cause of cancer death in women after lung cancer, according to the American Cancer Society.

Results showed that young Black women with triple-negative breast cancer – a more aggressive form of the disease – remained the highest-risk group.

However, researchers also found increased death risk among Hispanic and Asian women under 50, particularly those with triple-negative breast cancers.

“Importantly, we found that Asian women under 50 experience poorer outcomes and face elevated risk of mortality than previously recorded,” Wong said in a news release.

The results show that experts need to adopt a more nuanced approach when looking at breast cancer disparities, researchers said.

“Age, race, and tumor type should not be treated as separate issues as they interact to drive these disparities,” said lead investigator Lin Wang, a research fellow in the Wong Laboratory at Houston Methodist. “When we look at them together, we uncover risks that would otherwise remain hidden.”

Clinical Implications for Providers

These findings highlight the need for more personalized breast cancer screening, risk assessment, and treatment strategies for younger women of color. Researchers say providers should consider how age, race, and tumor subtype intersect when evaluating patients, particularly for those at risk for triple-negative breast cancer. Improving access to early detection, genetic counseling, culturally competent care, and clinical trials may help reduce persistent disparities in outcomes.

More information

The American Cancer Society has more about breast cancer.

SOURCE: Houston Methodist, news release, May 19, 2026

AI-Powered Search. Human-Created Content.

What is the most crucial step to reduce Black maternal mortality rates?

Based on: https://blackdoctor.pro/maternal-mortality-covid-black-women-disparities/

What is the most crucial step to reduce Black maternal mortality rates?

Expert Medical Insights, Straight to Your Inbox

Insights That Keep Black Healthcare Leaders at the Forefront

By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.

Top Articles

Empowering Culturally-Sensitive Healthcare Professionals

BlackDoctor Pro is an online destination created specifically for Black doctors and culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies. We are committed to empowering HCPs with the knowledge, resources, and support needed to achieve exceptional health outcomes in black communities.
Copyright © 2026, BlackDoctor, Inc. All rights reserved.
BlackDoctor Pro is an online destination created specifically for Black doctors and other culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies.
AI-Powered Search. Human-Created Content.